Publications

Alves, J., et al., A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice. PLoS One, 2015. 10(12): p. e0144196.

Oliveira, L., et al., Group B streptococcus GAPDH is released upon cell lysis, associates with bacterial surface, and induces apoptosis in murine macrophages. PLoS One, 2012. 7(1): p. e29963.

Madureira, P., et al., Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment. PLoS Pathog, 2011. 7(11): p. e1002363.

Madureira, P., et al., Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J Immunol, 2007. 178(3): p. 1379-87.

Tiago Pereira Rodrigues. Study the accessibility of IL-10 locus in a murine model of Neonatal Sepsis. MSc Thesis in Bioengineering, 2017. FEUP, University of Porto.

Cristiana Andreia Pereira Nogueira. Evaluation of the efficacy of a peptide-based vaccine (PNV1) against multi-resistant gram-negative bacteria in a neonatal mice model. MSc Thesis in Bioengineering, 2017. FEUP, University of Porto.

Filipa Gláucia Rodrigues Lemos. Study of the cellular and molecular mechanism associated with neonatal susceptibility to bacterial infections. MSc Thesis in Biochemistry, 2016. FCUP, University of Porto.

Pedro Madureira & Paula Ferreira (2015). Vaccine for Immunocompromised Hosts. WO2015/189422.

Pedro Madureira (2020). Immunogenic compositions. European Patent Application No. 20398008.1

Madureira P. Bacterial GAPDH as a target to prevent bacterial infections. ECCMID. April 2022. Lisbon, Portugal.

Madureira P. Development of novel anti-bacterial immunotherapies. World Vaccine and Immunotherapy Congress. December 2020. San Francisco, USA (virtual event)

Madureira P. Development of a virulence-targeted vaccine to prevent infections caused by MDR bacteria. 19th World Vaccine Congress. October 2018. Lisbon, Portugal.

Madureira P. Anti-bacterial Immunotherapies. 15th World Vaccine Congress. November 2015. Madrid, Spain.

Madureira P. Influence of the intestinal flora on the development of gut-associated immune responses. XIX NEDAI Annual Meeting. April 2013. Vila Moura, Algarve, Portugal.

Madureira P. Vaccine against GBS infection. i-techpartner Healthcare Biotech Forum Rome. March 2009. Rome, Italy.

M Vieira, L Curado, A Marques, F Lemos, C Teixeira, A Fidalgo, C Nogueira, T Rodrigues, P Ferreira & P Madureira. “Antibody-mediated neutralization of a conserved extracellular immunomodulatory protein prevents neonatal sepsis caused by multidrug-resistant bacteria”. XLIII SPI Annual Meeting. June 2017. Porto, Portugal.

P Melo, EB Andrade, J Alves, A Ribeiro, P Ferreira and P Madureira. “Targeting Bacterial GAPDH to Prevent Neonatal Sepsis”. XL SPI Annual Meeting. October 2014. Lisboa, Portugal.